发明名称 Use of ifn-alpha and amantadine for the treatment of chronic hepatitis
摘要 The present invention provides a method for treating chronic hepatitis C infections in patients in need of such treatment comprising administering an amount of IFN-alpha in association with an amount of amantadine effective to treat hepatitis C. In accordance with the invention, IFN-alpha and amantadine are administered at the same time or sequentially. The present invention also provides a kit for treating a hepatitis C infection containing IFN-alpha and amantadine in suitable dosage forms for administering the combination therapy.
申请公布号 AU9743098(A) 申请公布日期 1999.04.05
申请号 AU19980097430 申请日期 1998.09.11
申请人 F.HOFFMANN-LA ROCHE AG 发明人 FRIEDERIKE ZAHM
分类号 A61K38/21;A61P1/16;A61P31/12 主分类号 A61K38/21
代理机构 代理人
主权项
地址